Clinical Trials Browser

HER2-positive Breast Cancer × Thoracic × 1 year × Clear all

NCT05514717 2025-07-11

A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2

Phase 1 Recruiting

BreastGastrointestinalThoracic

HER2-positive Breast Cancer